Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

HomeProduct name listH-TRP-GLU-OH

H-TRP-GLU-OH

Synonym(s):H-Trp-Glu-OH;L-Tryptophyl-L-glutamic acid;PPARγ Antagonist III, G3335 - CAS 36099-95-3 - Calbiochem;WE

H-TRP-GLU-OH Structural

What is H-TRP-GLU-OH?

The Uses of H-TRP-GLU-OH

A cell-permeable dipeptide that acts as a selective and reversible peroxisome proliferator-activated receptor antagonist

What are the applications of Application

PPARγ Antagonist III, G3335 is a cell-permeable dipeptide that acts as a selective PPAR-γ antagonist

Definition

ChEBI: Trp-Glu is a dipeptide formed from L-tryptophan and L-glutamic acid residues. It has a role as a metabolite.

Biological Activity

kd = 8.34 μmg3335 is a pparγ antagonist.the peroxisome proliferator-activated receptor gamma (ppargamma) is a key therapeutic drug target for several conditions, such as inflammation, diabetes, hypertension, dyslipidemia, and cancer.

in vitro

biacore 3000 study based on the surface plasmon resonance technique found that g3335 exhibited a highly specific binding affinity against ppargamma and was able to block rosiglitazone, a potent ppargamma agonist, in the stimulation of the interaction between the ppargamma ligand-binding domain (lbd) and rxralpha-lbd. moreover, the yeast two-hybrid assays indicated that g3335 had strong antagonistic activity in perturbing rosiglitazone in the promotion of the ppargamma-lbd-cbp interaction. in addition, g3335 could competitively bind to ppargamma against 0.1 microm rosiglitazone to repress reporter-gene expression [1].

in vivo

in a previous study, the effect of rosiglitazone was examined on spinal cord injury (sci) in rats. the animals were randomly divided into vehicle group, rosiglitazone treated group, and g3335 treated group. locomotor function recovery was evaluated. results showed that compared with the vehicle groups, the rosiglitazone could significantly ameliorate locomotor recovery, reduce nf-κb expression, and increase the proliferation of endogenous npcs. in addition, when the ppar-γ antagonist g3335 was applied, such effects were abolished [2].

References

[1] ye, f. ,zhang, z.s.,luo, h.b., et al. the dipeptide h-trp-glu-oh shows highly antagonistic activity against pparγ: bioassay with molecular modeling simulation. chembiochem 7, 74-82 (2006).
[2] meng, q. q.,liang, x.j.,wang, p., et al. rosiglitazone enhances the proliferation of neural progenitor cells and inhibits inflammation response after spinal cord injury. neuroscience letters 503, 191-195 (2011).

Properties of H-TRP-GLU-OH

Melting point: >163°C(dec.)
Boiling point: 720.7±60.0 °C(Predicted)
Density  1.428±0.06 g/cm3(Predicted)
storage temp.  -15°C
solubility  Chloroform (Slightly), DMSO (Slightly)
form  White solid
pka 3.02±0.10(Predicted)
color  white to off-white
Sensitive  Light Sensitive

Safety information for H-TRP-GLU-OH

Computed Descriptors for H-TRP-GLU-OH

Related products of tetrahydrofuran

You may like

Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.